US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 278.190
  • +2.650+0.96%
Trading Jan 24 13:06 ET
35.88BMarket Cap-106.18P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q3
Stock NameRevenueRatio
AMVUTTRA258.59M51.62%
GIVLAARI71.04M14.18%
Net revenues from collaborations57.39M11.46%
ONPATTRO50.29M10.04%
OXLUMO40.22M8.03%
Royalty revenue23.39M4.67%
View all
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States689.02M37.69%
Net revenues from collaborations546.19M29.87%
Europe399.34M21.84%
Rest of world153.12M8.37%
Royalty revenue40.63M2.22%
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Collegium Pharmaceutical
COLL
+2.28%
Constellation Brands
STZ
+1.60%
Workday
WDAY
+1.23%
DexCom
DXCM
+0.96%
SilverCrest Metals
SILV
+0.75%

Unlock the Full List